Nanotechnology in Pharmaceuticals
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 924
Special Issue Editors
Interests: pharmaceutics
Interests: drug delivery; nanotechnology; formulation development; pharmacokinetics and osteoarthritis
Interests: drug delivery; nanomedicine; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The introduction of nanotechnology into pharmaceutical sciences has revolutionized therapeutic outcomes. The journey began with the first report of liposomes in 1964 followed by the first regulatory approval of DOXIL in 1995, leading to around 100 commercial products to date. Nanotechnology in pharmaceuticals has evolved significantly with the development of diverse nanocarriers, including micelles, lipid nanoparticles, inorganic nanoparticles, polymeric nanoparticles, protein-based nanoparticles, polymer–lipid hybrid nanoparticles, polymer–drug conjugates, lipid–drug conjugates, protein– and peptide–drug conjugates, and polymersomes.
A major advantage of nanotechnology lies in the nanosize of drug carriers with large surface areas, which helps in delivering the drug across biological barriers, widening its applicability in improving bioavailability and solubility, protecting the drug from degradation, and ensuring controlled/sustained release. As a result, it has been widely adopted in treating infectious, chronic, genetic, degenerative, and autoimmune diseases, as well as cancer. Advances in nanotechnology aided in designing targeted nanoparticles for precise delivery to the site of action and more biocompatible biomimetic nanoparticles, DNA-based nanoparticles, and biological nanoparticles, including lipoprotein and ferritin. With the remarkable impact of nanotechnology in pharmaceuticals, this Special Issue aims to highlight the wide applicability of nanotechnology in various aspects of therapeutics, diagnostics, and theranostics, encompassing numerous routes of administration, which include oral, intravenous, intramuscular, subcutaneous, ocular, pulmonary, topical, and intranasal. Hence, we invite reviews and research articles focusing on nanotechnology in various aspects of pharmaceuticals, including, but not limited to, small- and biomolecule delivery, diagnosis, advancements, and updates.
Dr. Pratap Basim
Dr. Geetha Vaskuri
Dr. Nagavendra Kommineni
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- drug delivery
- diagnostics
- theranostics
- biomimetics
- nanocarriers
- targeted delivery
- routes of administration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
